In adult healthy beagle dogs, plasma concentrations of ACTH, cortisol, α-MSH, GH, prolactin and arginine vasopressin (AVP) were measured after i.v. administration of [d-Ala2,N-Me-Phe4,Met-(O)5-ol]-enkephalin (DAMME) at doses of 0·1, 0·5, 1, 5 and 10 μg/kg body weight. Significant dose-dependent increases occurred for ACTH, cortisol and GH at dose rates of 0·5, 1, 5 and 10 μg/kg body weight. Increments in plasma concentrations of prolactin were significant only at 5 and 10 μg DAMME/kg, and there was no significant effect on plasma concentrations of α-MSH and AVP. Prior i.v. administration of the opiate antagonist naloxone (0·1 mg/kg) attenuated the DAMME (10 μg/kg)-stimulated release of ACTH and cortisol. The results demonstrate that the [Met]-enkephalin analogue DAMME stimulates the release of ACTH, cortisol, GH and prolactin in dogs, and that this stimulation is, at least in part, mediated by μ-opioid receptors. The observations for ACTH and cortisol are different from those in man, where DAMME lowers their basal concentrations.
Journal of Endocrinology (1990) 127, 265–271
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 2 | 0 | 0 |
PDF Downloads | 2 | 0 | 0 |